Patent · US Revoked

Radioimaging applications of and novel formulations of teboroxime

US8481946B2 · kind B2 · utility

0Cited by
550References
59Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 13, 2007
Grant dateJul 9, 2013
Priority date
Expiry dateMar 31, 2028

Classification

  • Technology area (CPC —)General

Abstract

A method for cardiac imaging is provided, including administering to an adult human subject an amount of a teboroxime species having a radioactivity of less than 5 mCi at a time of administration, and performing a SPECT imaging procedure of a cardiac region of interest (ROI) of the subject. Other embodiments are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.